APA

Giebel S., Kruzel T., Czerw T., Sadus-Wojciechowska M., Najda J., Chmielowska E., Grosicki S., Jurczyszyn A., Pasiarski M., Nowara E., Glowala-Kosinka M., Chwieduk A., Mitrus I., Smagur A. & Holowiecki J. (20140204). Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers. : Bone marrow transplantation.

Chicago

Giebel S, Kruzel T, Czerw T, Sadus-Wojciechowska M, Najda J, Chmielowska E, Grosicki S, Jurczyszyn A, Pasiarski M, Nowara E, Glowala-Kosinka M, Chwieduk A, Mitrus I, Smagur A and Holowiecki J. 20140204. Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers. : Bone marrow transplantation.

Harvard

Giebel S., Kruzel T., Czerw T., Sadus-Wojciechowska M., Najda J., Chmielowska E., Grosicki S., Jurczyszyn A., Pasiarski M., Nowara E., Glowala-Kosinka M., Chwieduk A., Mitrus I., Smagur A. and Holowiecki J. (20140204). Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers. : Bone marrow transplantation.

MLA

Giebel S, Kruzel T, Czerw T, Sadus-Wojciechowska M, Najda J, Chmielowska E, Grosicki S, Jurczyszyn A, Pasiarski M, Nowara E, Glowala-Kosinka M, Chwieduk A, Mitrus I, Smagur A and Holowiecki J. Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers. : Bone marrow transplantation. 20140204.